Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kauffman Michael
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   800,347    

Indirect Shares

   898,131      
Direct Value   $817,123    

Indirect Value

   $925,075      
Total Shares   1,698,478      
Total Value   $1,742,198      


Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $735,170 Verastem, Inc. $28,480 Kezar Life Sciences, Inc. $45,214 Adicet Bio, Inc $8,260 Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $735,170 Verastem, Inc. $28,480 Kezar Life Sciences, Inc. $45,214 Adicet Bio, Inc $8,260
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    12    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    12    
   
     Gain/Loss Ratio :
   0.0   
   -12.0   
     Percentage Gain/Loss :
     0.0%
 -553.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX Chief Medical Officer 2010-02-09 9,000 2009-11-16 0    Premium*  
            Karyopharm Therapeutics Inc. KPTI Director 2022-02-28 713,757 2022-02-28 898,131    Premium*  
            Verastem, Inc. VSTM Director 2018-09-28 8,000 2014-09-17 0    Premium*  
            Kezar Life Sciences, Inc. KZR Director 2022-01-03 63,690 2018-06-25 0    Premium*  
            Adicet Bio, Inc ACET 2024-06-05 5,900 2023-06-01 0    Premium*  
* Premium Members only  

Records found :    158         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-01-09 4 OE $4.75 $47,520 D/D 10,000 552,139 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-11 4 OE $4.75 $47,520 D/D 10,000 552,139 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-19 4 S $16.48 $145,321 D/D (8,817) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-03-10 4 AS $22.11 $222,186 D/D (10,000) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-04-09 4 AS $20.64 $206,404 D/D (10,000) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-07 4 AS $19.63 $147,209 D/D (7,500) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-10 4 AS $18.13 $135,944 D/D (7,500) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2015-12-30 5 GD $0.00 $0 D/D 3,144 559,452 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2015-01-12 4 S $33.00 $825,000 D/D (25,000) 562,596 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-07 4 OE $4.75 $35,640 D/D 7,500 562,622 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-10 4 OE $4.75 $35,640 D/D 7,500 562,622 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2021-02-11 4 S $15.52 $102,441 D/D (6,601) 562,821 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-15 4 OE $0.00 $0 D/D 21,800 563,939 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-03-10 4 OE $4.75 $47,520 D/D 10,000 565,122 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-04-09 4 OE $4.75 $47,520 D/D 10,000 565,122 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2021-02-05 4 OE $0.00 $0 D/D 14,300 569,422 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2021-02-18 4 S $14.83 $140,822 D/D (9,495) 575,126 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2021-02-15 4 OE $0.00 $0 D/D 21,800 584,621 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2014-07-02 4 S $42.50 $4,250,000 D/D (100,000) 587,596 0 -
KPTI Karyopharm Therapeutics I... President, C.E.O., C.M.O.Offic   •       •      –    2013-11-05 3 IO $0.00 $0 D/D 0 620,771 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2014-06-18 4 AS $43.15 $431,523 D/D (10,000) 687,596 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2013-12-20 5 GD $0.00 $0 D/D 55,750 697,596 0 -
KPTI Karyopharm Therapeutics I... Director   –       •      –    2022-02-17 4 S $12.12 $110,068 D/D (9,079) 698,983 0 %
KPTI Karyopharm Therapeutics I... Director   –       •      –    2022-02-07 4 S $9.86 $66,707 D/D (6,764) 708,062 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2017-12-07 4 AS $10.39 $103,903 I/I (10,000) 713,510 0 -
  158  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us